MHC-class-I expression in human breast cancer correlates with nuclear localization of the 90 kDa heat-shock-protein

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5293-5297

  Gebhard, Barbara ^a   Schütz, Gerti ^a   Ecker, Rupert Ch ^a   Steiner, Georg E ^a   Rudas, Margaretha ^a   Gnant, Michael ^a   Oehler, Rudolf ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast cancer; Heat shock proteins; HSP90; MHC class 1

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SIGNAL TRANSDUCTION; STAINING;

BREAST NEOPLASMS; CELL NUCLEUS; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HSP90 HEAT-SHOCK PROTEINS; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0033382131     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Carrido F, Cabrera T, Concha A, Glew S, Ruiz Cabello F and Stern PL: Natural history of HLA expression during tumour development. Immunol Today 14: 491-9, 1993.
2. Solana R, Rolnero J, Alonso C and Pena J: MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors. Invasion-Metastasis 12: 210-7, 1992.
3. Concha A, Esteban F, Cabrera T, Ruiz Cabello F and Garrido F: Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol 2: 47-54, 1991.
4. Garrido F, Ruiz Cabello F, Cabrera T, Perez Villar JJ, Lopez Botet M, Duggan Keen M and Stern PL: Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 18: 89-95, 1997.
5. York IA and Rock KL: Antigen processing and presentation by the class I major histocompatibility complex. Ann Rev Immunol 14: 369-396, 1996.
6. Lindquist S and Craig EA: The heat-shock proteins. Annu Rev Genet 22: 631-77, 1988.
7. Pratt WB: The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 37: 297-326, 1997.
8. Smith DF: Sequence motifs shared between chaperone components participating in the assembly of progesterone receptor complex. Biol Chem 379: 283-288, 1998.
9. Srivastava PK: Heat shock proteins in immune response to cancer: the Fourth Paradigm Experientia 50: 1054-60, 1994.
10. Fuqua SA and Wolf DM: Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res Treat 35: 233-241, 1995.
11. Maiorana A, Cesinaro AM, Fano RA and Collina G: Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases. Clin Exp Metastasis 13: 43-48, 1995.
12. Jameel A, Law M, Coonlbes RC and Luqmani Y: Significance of heat shock protein 90 as a prognostic indicator in breast cancer. Int J Oncol 2: 1075-1080, 1993.
13. Conroy SE and Latchman DS: Do heat shock proteins have a role in breast cancer? Br J Cancer 74: 717-21, 1996.
14. Pratt WB: The hsp90-based chaperone system involvement in signal transduction from a variety ol hormone and growth factor receptors Proc Soc Exp Biol Med 217: 420-34, 1998.
15. Kang KI, Devin J, Cadepond F, Jibard N, Guiochon Mantel A, Baulieu EE and Catelli MG: In vivo functional protein-protein interaction: nuclear targeted hsp90 shifts cytoplasmic steroid receptor mutants into the nucleus. Proc Natl Acad Sci USA 91: 340-4, 1994.
16. Udono H and Srivastava PK: Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178: 1391-6, 1993.
17. Suto S and Srivastava PK: A mechanism for specific immunogenicity of heat shock protein-chaperoned peptides. Science 269: 1585-1587, 1995.
18. Dasgupta G and Momand J: Glendamycin prevents nuclear translocation of mutant p53. Exp Cell Res 237: 29-37, 1997.
19. Galea-Lauri J, Richardson AJ, Latchman DS and Katz DR: Increased heat schock protein 90 (HSP90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide. J Immunol 157: 4109-4118, 1996.